Skip to main content
. 2016 Jan 20;5(1):e8. doi: 10.2196/resprot.5214

Table 2.

Baseline characteristics, anthropometrics, and laboratory values of the participants upon enrollmenta.

Variablesb Total (N=1050) Female (N=807) Male (N=243) P value
Age, year, mean (SD) 37.8 (11.7) 38.6 (11.8) 35.2 (11) .036
Age group, n (%) <.001

<20 52 (4.2) 39 (4.1) 13 (4.9)

20-29 229 (21.8) 162 (19.7) 67 (28.2)

30-39 339 (32.8) 251 (31.8) 88 (36.7)

40-49 241 (22.8) 197 (24.3) 44 (17.5)

50-59 148 (14.7) 123 (15.8) 25 (10.9)

60-69 39 (3.5) 34 (4.1) 5 (1.3)

≥70 2 (0.2) 1 (0.1) 1 (0.4)
Marital status, n (%) .014

Single/never married 252 (24.1) 169 (25.2) 83 (37.6)

Married 668 (61.7) 526 (62.7) 142 (58.4)

Divorced 62 (6.2) 52 (6.4) 10 (4.1)

Widowed 46 (3.6) 46 (5.7) 0
Education, n (%) .024

No education 10 (1.0) 7 (0.9) 3 (1.2)

Primary school 27 (13.8) 23 (15.0) 4 (1.8)

College 531 (50.7) 430 (52.2) 101 (45.9)

University 448 (34.5) 321 (32.1) 127 (43.1)
Employment status, n (%) <.001

Unemployed 567 (54) 521 (64.6) 46 (18.9)

Employed 458 (46) 261 (35.4) 197 (81.1)
Smoking status, n (%) <.001

Never smokers 819 (71.2) 661 (78.9) 158 (44.9)

Current smokers 156 (15.4) 89 (11.2) 67 (30)

Former smokers 143 (13.4) 80 (9.9) 63 (25.1)
Hookah use, n (%) 163 (15.5) 91 (11.3) 72 (29.6) .004
Alcohol consumption, n (%) 150 (14.3) 86 (10.7) 64 (26.3) .004
Comorbidities, n (%)

Hypothyroidism 186 (17.8) 169 (18.5) 17 (6.5) <.001

Hypertension 174 (17.6) 137 (17.1) 37 (15.3)

Dyslipidemia 168 (16.0) 137 (17.0) 31 (12.8)

Arthritis 167 (15.9) 144 (17.8) 23 (9.5) .039

Diabetes mellitus 158 (16.6) 127 (17.3) 31 (8.9)

Cardiovascular disease 63 (6.0) 47 (5.8) 16 (6.6)

Liver Enlargement 350 (92.1) 287 (72.4) 63 (83.5)

Fatty liver 106 (27.5) 87 (27.4) 19 (27.5)


Grade I 134 (35.2) 124 (41.4) 10 (17.1)


Grade II 155 (40.7) 125 (41.6) 30 (45.4)


Grade III 61 (16.2) 38 (17.0) 23 (33.3)

Gallstones 34 (7.1) 30 (7.4) 4 (5.1)
Anthropometrics, mean (SD)

Height, cm 163.5 (8.3) 161.2 (6.1) 175.5 (7.8) <.001

Weight, kg (range 74-195) 118.6 (20.7) 114 (17.1) 142.6 (20.9) <.001

BMI, kg/m2 (range 32.4-79.3) 43.9 (7.1) 43.8 (5.9) 46.2 (5.5) .09

BMI group (kg/m2), n (%) .054


25-29.9 9 (0.9) 8 (1) 1 (0.4)


30-34.9 68 (6.3) 57 (7.4) 11 (4.4)


35-39.9 243 (23.2) 197 (24.2) 46 (19.9)


40-44.9 332 (32.1) 261 (32.5) 71 (30.7)


45-49.9 235 (22.4) 176 (21.5) 59 (25.5)


50-54.9 99 (9.3) 67 (8.2) 32 (13)


55-59.9 42 (3.7) 24 (3.1) 18 (6.9)


60-64.9 13 (1.3) 9 (1.2) 4 (1.7)


65-69.9 7 (0.7) 6 (0.8) 1 (0.4)


≥70 2 (0.2) 2 (0.3) 0 (0.0)

Waist circumference, cm 125.1 (13.9) 122.5 (12.6) 138 (12.6) <.001

Hip circumference, cm 133.6 (12.7) 133.5 (13) 134.4 (11.1) .065

Neck circumference, cm 39.1 (3.9) 37.9 (2.8) 44.7 (3.4) <.001

Wrist circumference, cm 17.9 (1.6) 17.6 (1.4) 19.5 (1.7) <.001

SBP, mmHg 120.1 (16.7) 119.4 (16.6) 124.1 (16.5)

DBP, mmHg 75.9 (11.8) 75.3 (11.6) 79 (12.7)

Fat mass, % 49.8 (3.9) 50.6 (3.2) 46 (4.7) <.001

Fat mass, kg 58.2 (11.9) 6.9 (10.8) 64.4 (15) <.001

Fat free mass, kg 59 (11.4) 55.5 (7.5) 75.9 (12) <.001
Laboratory values, mean (SD)

FPG, mg/dl 107.9 (34.5) 109.4 (36.5) 99.6 (18.8) <.001

HbA1C, % 5.6 (1) 5.6 (1.1 5.6 (0.7) .037

TG, mg/dl 152.7 (76) 150.3 (70.9) 164.8 (97.7)

Cholesterol, mg/dl 192.4 (38) 193.5 (37.4) 186.6 (41.4) .033

HDL, mg/dl 49.6 (10.9) 50.2 (10.8) 46.3 (10.5) .001

LDL, mg/dl 112.5 (32.2) 113 (31.7) 109.6 (35.0)

Hemoglobin, g/dl 13.5 (1.5) 13.2 (1.2) 15.2 (1.4) <.001

Hematocrit, % 41.0 (3.9) 40.2 (3.2) 45.7 (3.5) <.001

AST, U/l 23.4 (15.5) 21.8 (12.8) 29.2 (18.6) .007

ALT, U/l 28.7 (21.3) 26.1 (15.5) 41.3 (31.3) <.001

Alkaline phosphatase, IU/l 191.8 (57.7) 191.4 (56.5) 194 (63.8)

aFor continuous variables, t test was used. For categorical variables, Pearson chi-square test was used.

bSBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; HbA1C: hemoglobin A1C; TG: triglyceride; HDL: high-density lipoprotein, LDL: low-density lipoprotein; AST: aspartate aminotransferase; ALT: alanine aminotransferase